Background : As intravenous thrombolysis (IVT) has very restricted inclusion criteria, eligible patients of IVT constitute a very small proportion and studies about their mortality are rare. The long-term mortality in a patients with contraindication of ineligible patients of IVT still under the debate. So, we investigated the proportion of patients with contraindication of IVT and the short and long-term mortality of them in AIS on emergency department comparing with the long-term effect of IVT in patients with moderate-to-severe stroke. Methods : Using acute stroke assessment indication registry & Health Insurance Review and Assessment Service database, a total of 5,407 patients with NIHSS≥5 were selected from a total of 169 acute stroke care hospital nationwide during October-December 2011 and March-June 2013. We divided AIS patients into two groups: 1) IVT group who received IVT within 4.5 hours, and 2) non-IVT group who did not receive the IVT because of contraindications. And we divided the subgroups according to the reason of contraindication of IVT. The 5-year survival rate of each group was assessed using Kaplan-Meyer survival analysis. Results : Of the 5,407 patients, a total of 1,027 (19%) patients who received IVT using r-tPA within 4.5 h after onset. Compared with the IVT group, hazard ratios of non-IVT group were 1.33 at 3 months, 1.53 at 1 year and 1.47 at 5 years (p<.001). A total of 4,380 patients did not receive IVT because of the following contraindications to IVT. 1) Time restriction: 3,378 (77.1 %) patients were admitted after 4.5 h following stroke onset, and 144 (3.3%) patients failed to determine the stroke onset time. 2) Mild symptoms:137 (3.1%) patients had rapid improvement or mild stroke on emergency room, 3) Bleeding diathesis or non-adjustable hypertension: 53 (1.2%) patients showed a bleeding tendency or severe hypertension. Compared with the IVT group, the subgroups of non-IVT group showed consistently high mortality during short and long term follow up. Mild symptom and bleeding diathesis or non-adjustable hypertension subgroup in the non-IVT group consistently showed the higher mortality than time restriction subgroup during the short and long-term follow-up (log-rank p<.001). Patients who had rapid improvement or mild stroke on emergency department had the higher mortality than time restriction group in short and long term follow up. Conclusion : The AIS patients with rapid improvement or mild stroke on emergency room had higher mortality than ineligible patients of IVT due to time restriction during the short and long-term follow-up. A further management and special support on emergency department is needed for these patients with initially mild stroke and rapid improvement in AIS to reduce the poor outcome.
INTRODUCTION
Intravenous thrombolysis (IVT) using recombinant tissue plasminogen activator (r-tPA) is a primary treatment for acute ischemic stroke (AIS). It is associated with improved functional outcome at 3 months.
However, it is still debated whether IVT reduces the mortality or improved the functional outcome during long-term follow-up. In addition, most large randomized controlled studies had investigated with a limited period until 3 or 12 months. 16 Previous studies were limited in representing general population because they were performed at expert stroke centers with well-designed protocols.
Clinical trial results should be generalized to patients treated in routine clinical practice, which also needs to be confirmed during long-term follow-up in general population. Due to these limitations of previous studies, the influence of IVT should be investigated to determine the absolute and relative contraindications for the procedure. Since most of these studies presented short-term outcomes (within 6 months),
long-term studies of IVT in large-sized samples are needed.
We investigated the differences in long-term prognosis between patients who received IVT and those who did not due to contraindications. To assess the differences in mortality based on the contraindications, we studied the short and long-term mor- We defined as an AIS patient who was diagnosed with ischemic stroke (ICD-10:163) as the first-onset stroke and was admitted via emergency room during the study period. A total of 5,407 patients above the age of 18 years were selected from a total of 169 medical institutions. Enrolled hospitals were randomly selected from the hospitals with at least 100 beds and more than 10 AIS patients per year. We collected clinical data and medical records of AIS patients sent automatically to HIRA. And we collected data about the mortality of selected patients using both the administrative data and HIRA. So, these data are regarded as very highly reliable and accurate for study about the long term mortality. Table 2 . The medical aid group had higher HR than the health insurance group (p<.001). Factors influencing the short and long-term mortality on AIS are summarized in Table 3 .
Study population and grouping
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Survival rates of IVT and non-IVT groups during long-term follow-up
Compared with the IVT group, both time-restricted and mild symptom subgroups in the non-IVT group manifested a lower survival rate during 5 years.
Bleeding diathesis or non-adjustable hypertension subgroup had the lowest survival rate during long-term follow-up (log-rank p<.001). Interestingly, we could fine the IVT group as well as each group consistently affect not only the short-term, but also the long-term prognosis in patients of AIS (Fig 1) .
DISCUSSION
Our result showed the current status of acute stroke management in Korea and the long term mortality according to acute management on emergency department using very reliable data of HIRA and acute stroke assessment indication registry. Using reliable and valid data in stroke registry and information collected by HIRA, we showed that the rate of IVT in AIS was also low at 19% despite good medical and hospital access in Korea. In addition, the long-term mortality of non-IVT group was higher than in IVT , and higher pretreatment systolic blood pressure was not independently associated with outcome. In patients undergoing IVT, no significant difference was found between those manifesting severe hypertension and sICH. 5) In addition, the use of antihypertensives to achieve stable blood pressure control in patients prior to r-tPA appears to be safe.
Despite a platelet count <100 000/mm 3 being a con- In these specific issues, further studies are needed.
We found that the IVT consistently affected not only the short-term, but also the long-term prognosis in patients diagnosed with AIS. In addition, despite patients with MT representing a small number in this study, they also affected the short and long-term mortality. Active management in critical to improve the functional status and reduce the mortality rate. to IVT should be conducted to reduce the mortality and improve the outcomes in AIS.
In the current study, the application rate of MT among the total AIS patients was very low at 8.5%.
MT was performed with 21.2% in IVT group and 5.5% in non-IVT group. These data were collected 
CONCLUSION
The long-term prognosis of patients who failed to receive IVT was very poor. Especially, the two subgroups with mild symptoms and bleeding diathesis or non-adjustable hypertension as contraindications to IVT consistently showed very high mortality during short and long-term follow-up. Therefore, a further study to enlarge the indications of IVT or release the contraindications of IVT is needed to reduce the mortality in such patients diagnosed with AIS. In addition, a new strategy for MT in AIS should broaden to include patients contraindicated for IVT.
